Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pedro Bak-Gordon"'
Autor:
Noélia Custódio, Rosina Savisaar, Célia Carvalho, Pedro Bak-Gordon, Maria I. Ribeiro, Joana Tavares, Paula B. Nunes, Ana Peixoto, Carla Pinto, Carla Escudeiro, Manuel R. Teixeira, Maria Carmo-Fonseca
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 199 (2022)
Predictive biomarkers are crucial in clarifying the best strategy to use poly(ADP-ribose) polymerase inhibitors (PARPi) for the greatest benefit to ovarian cancer patients. PARPi are specifically lethal to cancer cells that cannot repair DNA damage b
Externí odkaz:
https://doaj.org/article/35fd3c7193d046c8884b97ed420fee1b
Autor:
Noélia, Custódio, Rosina, Savisaar, Célia, Carvalho, Pedro, Bak-Gordon, Maria I, Ribeiro, Joana, Tavares, Paula B, Nunes, Ana, Peixoto, Carla, Pinto, Carla, Escudeiro, Manuel R, Teixeira, Maria, Carmo-Fonseca
Publikováno v:
Biomedicines. 10(2)
Predictive biomarkers are crucial in clarifying the best strategy to use poly(ADP-ribose) polymerase inhibitors (PARPi) for the greatest benefit to ovarian cancer patients. PARPi are specifically lethal to cancer cells that cannot repair DNA damage b
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Copyright © 2019, Springer Nature Limited
Discoveries in the past decade have highlighted the potential of mRNA as a therapeutic target for cancer. Specifically, RNA sequencing revealed that, in addition to gene mutations, alterations in mRNA c
Discoveries in the past decade have highlighted the potential of mRNA as a therapeutic target for cancer. Specifically, RNA sequencing revealed that, in addition to gene mutations, alterations in mRNA c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c78c84bc5033bcd96eb906a6173285
Publikováno v:
Nature reviews. Drug discovery. 19(2)
Discoveries in the past decade have highlighted the potential of mRNA as a therapeutic target for cancer. Specifically, RNA sequencing revealed that, in addition to gene mutations, alterations in mRNA can contribute to the initiation and progression
Autor:
Custódio, Noélia, Savisaar, Rosina, Carvalho, Célia, Bak-Gordon, Pedro, Ribeiro, Maria I., Tavares, Joana, Nunes, Paula B., Peixoto, Ana, Pinto, Carla, Escudeiro, Carla, Teixeira, Manuel R., Carmo-Fonseca, Maria
Publikováno v:
Biomedicines; Feb2022, Vol. 10 Issue 2, p199, 1p